'Combination Of A Pd-1 Antagonist And A Vegfr/Fgfr/Ret Tyrosine Kinase Inhibitor For Treating Cancer' in Patent Application Approval Process (USPTO 20220023285)

Source :: Women's Health Weekly. February 17, 2022, 141
Publication Year :: 2022
Abstract: 2022 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DENKER, Andrew Evan (North Wales, PA, US); HORI, [...]

Subjects :: Merck Sharp & Dohme Corp. -- Intellectual property
Women -- Health aspects
Tyrosine -- Intellectual property
Phenols -- Intellectual property
Cancer -- Care and treatment
Palladium -- Intellectual property
Pharmaceutical industry -- Intellectual property
Health
Women's issues/gender studies

Tools